AZ’s Airsupra (albuterol and budesonide) – developed with Avillion – was approved by the FDA last year for as-needed treatment or prevention of asthma ... market for smart inhaler devices ...

Winter is here, and that can make it difficult for those with asthma to control their symptoms.The cold air that co ...

Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp ...

Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent symptoms to newly diagnosed sufferers who are 12 and over ...

Smart Inhalers Market The smart inhaler market advances respiratory care with tech-enabled devices, offering dose tracking, reminders, and data sharing for better health outcomes. AUSTIN, TX, UNITED S ...

Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and ...

SMART strategy in patients at least 12 years of age with uncontrolled asthma at GINA step 3 or 4. The simulated utility of switching to SMART was compared with continued use of fixed‐dose inhaled ...